To analyze the risk factors of anorectal stenosis associated with perianal fistulizing Crohn's disease (PFCD).
Background
Anal fistula is the most common perianal Crohn's disease (CD); about 35% of CD patients are complicated with anal fistula [1] , and it is the initial symptom in 5% of CD patients [2] . We analyzed the data on perianal fistulizing Crohn's disease (PFCD) from January 2010 to December 2017 in the Department of Colorectal Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine (AHNUCM), and found that among 139 PFCD cases, 44 cases (31.7%) were complicated with anorectal stenosis, which exceeded the incidence rates of other complicated perianal lesions (such as verrucous dermatophytes, anal fissure, abscess and rectovaginal fistula) [3] . There is an abundance of literature on PFCD, but data on other types of perianal CD remain scarce. The epidemiological investigation of anorectal stricture in CD has not been reported. Fibrotic anorectal stricture in CD usually occurs as a result of chronic inflammation and often occurs late in the course of the disease [4] . Anorectal stenosis affects defecation functions, and even requires fecal diversion in severe cases. It has a severe impact on patients' daily life. In an attempt to minimize the incidence of anorectal stenosis of PFCD, we analyzed the clinical data of 139 cases to identify potential influencing factors.
Material and Methods

Data collection
In our research center, specialized Inflammatory Bowel Disease medical staff registered basic information such as sex, age, body mass index (BMI), asked for medical history such as CD course, anal fistula course, clinical symptoms, abdominal surgery history, perianal surgery history, and medication history, and performed examinations such as endoscopy, imaging, and laboratory tests of patients with PFCD who were hospitalized. These medical staff were trained to evaluate the patients according to the diagnostic criteria, clinical evaluation, and classification criteria. We recorded data on Montreal classification, anal fistula type, number of external openings, concomitant perianal lesions, CD activity index (CDAI), perianal disease activity index (PDAI) and some laboratory indexes.
We retrospectively analyzed the data of 139 cases of PFCD, who were hospitalized for the first time at the Department of Colorectal Surgery of AHNUCM from January 2010 to January 2017. The clinical information is shown in Table 1 . The patients were divided into 2 groups according to whether anorectal stenosis occurred, and then statistical analysis was conducted. This study conformed to the Helsinki Declaration and we obtained informed consent from all patients. The study was approved by the Ethics Committee of AHNUCM (approval number of 2017NL-071-02).
Diagnostic criteria
The diagnostic criteria for PFCD referred to "A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulizing Crohn's disease" published in 2014 by the World Gastroenterology Organization [5] . The diagnostic criteria of anorectal stenosis referred to "diagnostic basis, syndrome classification, and efficacy evaluation of anorectal stenosis" in "Criteria for the diagnosis and treatment of diseases and syndromes in internal medicine of traditional Chinese medicine" (ZY/T001.1-94), which is the Chinese medicine industry standard of the People's Republic of China [6] . Anorectal stenosis referred to the narrowing of the anal and rectal passages caused by any reason and leading to defecation difficulties. It was diagnosed based on difficult defecation, a history of perianal inflammation, anal injury or anorectal surgery, and index finger difficulty on examination.
Clinical evaluation and classification criteria
The nutritional status of the patients was assessed by BMI [7] , with 18.5~23.9 as normal and <18.5 and ³24 as abnormal. The classification of CD was conducted using the Montreal Phenotypic Classification proposed by the World Gastroenterology Working Group in 2005 [8] , which includes age (A), lesion site (L), and disease behavior (B). In this study, B2 type included anorectal stenosis, and B3 type excluded the penetration caused by anal fistula. The Best CDAI algorithm [9] was used to evaluate the activity index of CD: <150 points, very well;150~220 points, fair to good; 221~450 points, poor; >450, very poor. PDAI was used to evaluate the activity of PFCD [10] : £4 indicating remission stage and >4 indicating active stage. Classification of anal fistulas referred to the American Gastroenterological Association's medical position statement about perianal Crohn's disease in 2003 [11] , and divided into simple anal fistula and complex anal fistula. Simple anal fistula refers to a low (superficial fistula, low inter-sphincteric or trans-sphincter fistula), single, external opening, with no abscess signs such as pain or fluctuation, no rectovaginal fistula, and no anorectal stenosis, whereas complex anal fistula refers to the opposite. 
Multivariate logistic regression
Multivariate logistic regression analysis was conducted on the risk factors detailed above and variables that were clinically considered to be potentially influential to determine the independent risk factors of anorectal stenosis of PFCD. The results showed that mild (fair to good) (OR=3.833, 95% CI: 1.123~13.080) to moderate (poor) (OR=7.345, 95% CI: 1.964~27.474) CDAI and age at diagnosis (OR=1.067, 95% CI: 1.013~1.124) were independent risk factors for anorectal stenosis of PFCD ( Table 3) .
Treatment of patients with anorectal stenosis
We found that 86.4% (38 patients) of these anorectal stenosis patients received medication prior to the diagnosis of e920243-5 anorectal stenosis, and 4 of them had received biologic therapy previously ( Table 2 ). After the diagnosis of anorectal stenosis, these patients received anal dilatation or medication according to the component of the stenosis; 80% of them received dilatation under anesthesia because of fibrotic stenosis, and the others received a biologic agent or immunosuppressor because of inflammatory stenosis.
Discussion
Perianal CD and location of intestinal lesion
The incidence of perianal CD is closely related to the location of intestinal lesions, and it is significantly increased when inflammation involves the rectum [12, 13] . Anal fistula is associated with 12% of isolated ileal CD, 15% of ileal colon CD, 41% of colon CD when the rectum is not involved, and 92% of colon CD when the rectum is involved, and only 5% CD patients initially present with an anal fistula without any intestinal inflammation [14, 15] . Although the European Crohn's and Colitis Organization (ECCO) Consensus did not elaborate on the relationship between anorectal stenosis occurrence and intestinal inflammation location, our study showed that the anorectal stenosis incidence rate of colonic CD (48.6%) was higher than of ileac CD (18.2%) and ileocolic CD (29.0%), and the difference was statistically significant (P=0.019). Therefore, we speculated that incidence of anal fistula and anal anorectal stenosis of CD was correlated with distal intestinal lesions.
The development of CD itself can lead to damage to the internal and external sphincter and perineal body, and proctitis leads to decreased rectal compliance. Even a moderate level of sphincter function decline can eventually result in incontinence due to decreased colonic absorption of water, rectal capacity, and compliance. The only surgical method for anal fistula of CD complicated with proctitis is seton drainage, and deterministic surgical methods to promote fistula closure are not feasible [5] . When the anorectal stenosis is associated with proctitis, anal dilatation often leads to inflammation tissue bleeding, so medical treatment to control proctitis should be the first choice. Anal dilatation and sternotomy are more suitable for patients with fibrous stenosis. If the stenosis is extensive, it is difficult for patients to avoid bypass surgeries.
Anal fistula, anorectal stenosis, and intestinal inflammatory activity in CD
Previous studies showed that the risk factors of perianal lesions in CD are related not only to lesion location [16] [17] [18] , but also to sex, age, and race. However, no correlation between the incidence of CD perianal lesions and intestinal inflammatory activity has been reported. The results of the present study suggest that higher CDAI is associated with higher the risk of anorectal stenosis, meaning that the severity of intestinal inflammation of CD can directly affect the incidence of rectal stenosis. Most CD patients are initially diagnosed on the basis of pathological changes in inflammation. When diagnosed, only one-third of patients have evidence of stenosis or penetration. After chronic relapses, the inflammatory disease phenotype tends to shift to a stenosis and/or penetrating phenotype, characterized by serious complications such as stenosis or fistula. Epithelial mesenchymal transformation (EMT) is involved in tissue healing in response to traumas. When a tissue or organ is injured, it triggers a complex chain of healing reactions. This delicate process of tissue repair is important for stability of the internal environment of organs. However, the imbalance between excessive and inadequate tissue repair can impair organ function, with ulceration and fistula formation on the one hand, and fibrosis and stenosis on the other [19] . EMT seems to be the driving force for the development of fistulas and the key to the development of fibrosis [20, 21] . In this study, 31.7% of PFCD patients were complicated with rectal stenosis, more than with other complications, which confirms the theory that the mechanisms of development of anal fistula and fibrosis are similar. There is evidence showing that intestinal inflammation is the main driver of CD fibrosis [22, 23] . This evidence may also explain our observation that higher CDAI is associated with greater risk of rectal stenosis. In this study, the patients who had previously received medication had higher incidence of rectal stenosis (p=0.052), although the difference was not statistically significant. Why did the medication fail to control inflammation but lead to a higher incidence of stenosis? This may be related to the longer course of CD in these patients; 74 of the 102 patients who had previous medication had a CD course of more than 1 year. Inflammatory or fibrous stenosis can develop due to long-term inflammation under inappropriate medication. Age at diagnosis and PDAI were included as continuous variables.
